Post-approval studies (Phase 4)Study completedNCT03848507
What this trial is testing
Impact of Hyperoncotic Albumin to Support Blood Loss Replacement
Who this might be right for
Blood Loss, SurgicalFluid Retention
Insel Gruppe AG, University Hospital Bern 24